Patient group direction for Comirnaty® (Pfizer BioNTech)

Document first published:
Page updated:
Topic:
,
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® COVID-19 mRNA vaccine to individuals in accordance with the national COVID-19 vaccination programme.

Summary

Published 26 August 2021 and updated 20 September 2021.

Summary

Published 26 August 2021 and updated 20 September 2021.